Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q1 2024 Earnings

15FebConfirmed

Q2 2023

Q3 2023

Q4 2023

Q1 2024

-38.28

-15.35

7.59

30.52

Details

Expected EPS

-21.455910000000003

Actual EPS

-13.111945

Surprise EPS

8.34

Surprise Percent

+38.89%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -13.111945 per share for Q1 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.